ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma

Gastrointestinal Endoscopy

Volumn 80, Issue 5, 2014, Pages 794-804

  Strand, Daniel S ^a   Cosgrove, Natalie D ^a   Patrie, James T ^a   Cox, Dawn G ^a   Bauer, Todd W ^a   Adams, Reid B ^a   Mann, James A ^a   Sauer, Bryan G ^a   Shami, Vanessa M ^a   Wang, Andrew Y ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN; PHOTOFRIN II; PHOTOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PALLIATIVE THERAPY; CHOLANGITIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISTANT METASTASIS; DUODENOSCOPE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MALE; OVERALL SURVIVAL; PHOTODYNAMIC THERAPY; PLASTIC STENT; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; STENT COMPLICATION; STENT OCCLUSION; TREATMENT OUTCOME; BILE DUCT NEOPLASMS; CATHETER ABLATION; CHOLANGIOCARCINOMA; COMPARATIVE STUDY; COMPUTER ASSISTED SURGERY; DIODE LASER; INTRAHEPATIC BILE DUCT; MIDDLE AGED; MORTALITY; PALLIATIVE THERAPY; PHOTOCHEMOTHERAPY; PROCEDURES; SURVIVAL RATE; THERAPEUTIC USE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CATHETER ABLATION; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; COHORT STUDIES; DIHEMATOPORPHYRIN ETHER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LASERS, SEMICONDUCTOR; MALE; MIDDLE AGED; PALLIATIVE CARE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RETROSPECTIVE STUDIES; SURGERY, COMPUTER-ASSISTED; SURVIVAL RATE;

EID: 84927785796     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2014.02.1030     Document Type: Article

References (36)

1. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005;128: 1655-67.
2. Gores GJ, Nagorney DM, Rosen CB. Cholangiocarcinoma: is transplantation an option? For whom? J Hepatol 2007;47:455-9.
3. Anderson CD, Pinson CW, Berlin J, et al. Diagnosis and treatment of cholangiocarcinoma. Oncologist 2004;9:43-57.
4. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463-73; discussion 473-5.
5. Berr F, Wiedmann M, Tannapfel A, et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 2000;31:291-8.
6. Park J, Kim MH, Kim KP, et al. Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: A large-scale observational study. Gut Liver 2009;3: 298-305.
7. Skipworth JR, Olde Damink SW, Imber C, et al. Review article: surgical, neo-adjuvant, and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther 2011;34:1063-78.
8. Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: A single-center 34-year review of 574 consecutive resections. Ann Surg 2012;258:129-40.
9. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31-8.
10. Ito F, Agni R, Rettammel RJ, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg 2008;248:273-9.
11. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-17; discussion 517-9.
12. Kahaleh M, Mishra R, Shami VM, et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol 2008;6:290-7.
13. Pahernik SA, Dellian M, Berr F, et al. Distribution and pharmacokinetics of Photofrin in human bile duct cancer. J Photochem Photobiol B 1998;47:58-62.
14. Cheon YK, Lee TY, Lee SM, et al. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma. HPB (Oxford) 2012;14:185-93.
15. Witzigmann H, Berr F, Ringel U, et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to R1/R2 resection. Ann Surg 2006;244:230-9.
16. Allison RR, Zervos E, Sibata CH. Cholangiocarcinoma: An emerging indication for photodynamic therapy. Photodiagnosis Photodyn Ther 2009;6:84-92.
17. Gao F, Bai Y, Ma SR, et al. Systemic review: photodynamic therapy for unresectable cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2010;17:125-31.
18. Ortner ME, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: A randomized prospective study. Gastroenterology 2003;125:1355-63.
19. Zoepf T, Jakobs R, Arnold JC, et al. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 2005;100:2426-30.
20. Leggett CL, Gorospe EC, Murad MH, et al. Photodynamic therapy for unresectable cholangiocarcinoma: A comparative effectiveness systemic review and meta-analyses. Photodiagnosis Photodyn Ther 2012;9:189-95.
21. Hoblinger A, Gerhardt T, Gonzalez-Carmona MA, et al. Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma. Eur J Med Res 2011;16:391-5.
22. Kim JH, Won HJ, Shin YM, et al. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. AJR Am J Roentgenol 2011;196:205-9.
23. Fu Y, Yang W, Wu W, et al. Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma. J Vasc Interv Radiol 2012;23:642-9.
24. Park SY, Kim JH, Won HJ, et al. Radiofrequency ablation of hepatic metastases after curative resection of extrahepatic cholangiocarcinoma. AJR Am J Roentgenol 2011;197:1129-34.
25. Steel AW, Postgate AJ, Khorsandi S, et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc 2011;73:149-53.
26. Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:1206-22.
27. Figueroa-Barojas P, Bakhru MR, Habib NA, et al. Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: A novel palliation technique. J Oncol 2013;2013: 910897.
28. Alis H, Sengoz C, Gonenc M, et al. Endobiliary radiofrequency ablation for malignant biliary obstruction. Hepatobiliary Pancreat Dis Int 2013;12:423-7.
29. Sainani NI, Catalano OA, Holalkere NS, et al. Cholangiocarcinoma: current and novel imaging techniques. Radiographics 2008;28: 1263-87.
30. Blechacz B, Komuta M, Roskams T, et al. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011;8:512-22.
31. Grambsch P, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:11.
32. Dhanasekaran R, Hemming AW, Zendejas I, et al. Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep 2013;29:1259-67.
33. Peters RA, Williams SG, Lombard M, et al. The management of highgrade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses. Endoscopy 1997;29:10-6.
34. Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998;47:354-62.
35. Wiedmann M, Caca K, Berr F, et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: A phase II pilot study. Cancer 2003;97:2783-90.
36. Born P, Rosch T, Bruhl K, et al. Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage. Z Gastroenterol 2000;38: 483-9.